Toll Free: 1-888-928-9744

ChironWells GmbH - Product Pipeline Review - 2014

Published: Nov, 2014 | Pages: 22 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

ChironWells GmbH - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'ChironWells GmbH - Product Pipeline Review - 2014', provides an overview of the ChironWells GmbH's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ChironWells GmbH's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of ChironWells GmbH including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of ChironWells GmbH's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the ChironWells GmbH's pipeline products

Reasons to buy

- Evaluate ChironWells GmbH's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of ChironWells GmbH in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the ChironWells GmbH's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of ChironWells GmbH and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of ChironWells GmbH
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of ChironWells GmbH and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
ChironWells GmbH Snapshot 4
ChironWells GmbH Overview 4
Key Information 4
Key Facts 4
ChironWells GmbH - Research and Development Overview 5
Key Therapeutic Areas 5
ChironWells GmbH - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
ChironWells GmbH - Pipeline Products Glance 9
ChironWells GmbH - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
ChironWells GmbH - Drug Profiles 11
HS-198 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
HS-378 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
HS-731 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Small Molecule for Bowel Motility Disorders 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Small Molecule to Agonize OP3 Receptor for Inflammatory Bowel Diseases 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ChironWells GmbH - Pipeline Analysis 16
ChironWells GmbH - Pipeline Products by Target 16
ChironWells GmbH - Pipeline Products by Route of Administration 17
ChironWells GmbH - Pipeline Products by Molecule Type 18
ChironWells GmbH - Pipeline Products by Mechanism of Action 19
ChironWells GmbH - Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
Coverage 21
Secondary Research 21
Primary Research 21
Expert Panel Validation 21
Contact Us 22
Disclaimer 22
List of Tables
ChironWells GmbH, Key Information 4
ChironWells GmbH, Key Facts 4
ChironWells GmbH - Pipeline by Indication, 2014 6
ChironWells GmbH - Pipeline by Stage of Development, 2014 7
ChironWells GmbH - Monotherapy Products in Pipeline, 2014 8
ChironWells GmbH - Preclinical, 2014 9
ChironWells GmbH - Discovery, 2014 10
ChironWells GmbH - Pipeline by Target, 2014 16
ChironWells GmbH - Pipeline by Route of Administration, 2014 17
ChironWells GmbH - Pipeline by Molecule Type, 2014 18
ChironWells GmbH - Pipeline Products by Mechanism of Action, 2014 19 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify